Drugs that save infants' lives

Jul 22, 2010
An illustration used to encourage women in Tanzania to take the medication.

(PhysOrg.com) -- Researchers at the University of Sydney have found the combined intake of iron-folic acid supplements with World Health Organisation (WHO)-endorsed anti-malarial drugs during pregnancy could reduce early infant mortality in sub-Saharan Africa by a quarter.

Worldwide, approximately 247 million cases of malaria each year result in almost a million deaths, mostly among African children. There has been some suggestion the use of antenatal iron-folic acid supplement - generally recommended during all pregnancies - increases malaria among women and children in sub-Saharan Africa.

Researchers at the Sydney School of Public Health, led by Dr Christiana Titaley, analysed data from 19 malaria-endemic African countries to investigate the effect of combining iron-folic acid supplements with malarial during pregnancy. Specifically, they looked at the relationship between the use of these medications and neonatal death (during the first 30 days of life).

"Only about one sixth of the 185,000-plus women investigated took a combination of folic/iron supplements and WHO-recommended sulfadoxine-pyramethamine anti-malarial drugs during pregnancy," Dr Titaley says. "These women's children were 24 percent less likely to die in the first month of life than infants whose mothers used neither.

"The prevalence of malaria in many parts of Africa muddies the advice given to most expecting mothers to take iron/folic acid supplements to reduce the risk of and ," says Dr Titaley.

"Combining these with effective anti-malarial medication can significantly reduce in at-risk regions of the world. This is especially true in regions with limited health care resources.

"We hope these findings will help clarify the message to expecting mothers in such areas."

The paper Combined iron/folic acid supplements and malaria prophylaxis reduce neonatal mortality in 19 sub-Saharan African countries has been published in the latest edition of the American Journal of Clinical Nutrition.

Explore further: Health care organizations see value of telemedicine

Provided by University of Sydney

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Folic acid cuts risk of cleft lip

Jan 26, 2007

Taking folic acid supplements in early pregnancy seems to substantially reduce the risk of cleft lip, finds a new study published in the British Medical Journal.

Multivitamins in pregnancy reduce risk of low birth weights

Jun 08, 2009

Prenatal multivitamin supplements are associated with a significantly reduced risk of babies with a low birth weight compared with prenatal iron-folic acid supplementation, found a new study in the Canadian Medical Association Jo ...

Recommended for you

Health care organizations see value of telemedicine

Nov 27, 2014

(HealthDay)—Health care organizations are developing and implementing telemedicine programs, although many have yet to receive reimbursement, according to a report published by Foley & Lardner.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.